levetiracetam
Generic: levetiracetam
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam
Labeler
preferred pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
levetiracetam 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8843
Product ID
68788-8843_8c16bc7b-672c-420a-a457-350060533375
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091491
Listing Expiration
2026-12-31
Marketing Start
2025-03-20
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888843
Hyphenated Format
68788-8843
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA091491 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (68788-8843-1)
- 20 TABLET in 1 BOTTLE (68788-8843-2)
- 30 TABLET in 1 BOTTLE (68788-8843-3)
- 60 TABLET in 1 BOTTLE (68788-8843-6)
- 90 TABLET in 1 BOTTLE (68788-8843-9)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8c16bc7b-672c-420a-a457-350060533375", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["311289"], "spl_set_id": ["8c16bc7b-672c-420a-a457-350060533375"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8843-1)", "package_ndc": "68788-8843-1", "marketing_start_date": "20250320"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-8843-2)", "package_ndc": "68788-8843-2", "marketing_start_date": "20250320"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8843-3)", "package_ndc": "68788-8843-3", "marketing_start_date": "20250320"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8843-6)", "package_ndc": "68788-8843-6", "marketing_start_date": "20250320"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8843-9)", "package_ndc": "68788-8843-9", "marketing_start_date": "20250320"}], "brand_name": "Levetiracetam", "product_id": "68788-8843_8c16bc7b-672c-420a-a457-350060533375", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-8843", "generic_name": "Levetiracetam", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "500 mg/1"}], "application_number": "ANDA091491", "marketing_category": "ANDA", "marketing_start_date": "20250320", "listing_expiration_date": "20261231"}